The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Proteome-wide covalent ligand discovery in native biological systems
Open accessAbstract
Small molecules are powerful tools for investigating protein function and can serve as leads for new therapeutics. Most human proteins, however, lack small-molecule ligands, and entire protein classes are considered 'undruggable'. Fragment-based ligand discovery can identify small-molecule probes for proteins that have proven difficult to target using high-throughput screening of complex compound libraries. Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-molecule probes, including those that can access regions of proteins that are difficult to target through binding affinity alone. Here we report a quantitative analysis of cysteine-reactive small-molecule fragments screened against thousands of proteins in human proteomes and cells. Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chemical probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins. Among the atypical ligand-protein interactions discovered were compounds that react preferentially with pro- (inactive) caspases. We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines versus primary human T cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and -10. Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compounds that can illuminate protein functions in native biological systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although human CASP10 shares some degree of substrate specificity with CASP8 [317] and possibly contributes to extrinsic apoptosis in primary T cells [318]”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [318]
In the citing paper
“Covalent inhibitors have been reported to achieve high efficiency through forming covalent bonds with cysteine or other nucleophilic residues in the target protein.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [53]
In the citing paper
“Reactive cysteine residues on proteins have high nucleophilicity, which enables covalent binding with electrophilic small molecules [53, 54].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [53]
In the citing paper
“In this study, more than 700 ligandable cysteines were identified, and information was provided about the proteome-wide selectivity of each covalent fragment in the library.”
From Advances in covalent drug discovery (2022) · cites this paper as [180]
In the citing paper
“The use of competitive isoTOP-ABPP was expanded to identify proteome-wide targets of a small covalent fragment library by competing individual acrylamide and chloroacetamide fragments against an iodoacetamide–alkyne probe180.”
From Advances in covalent drug discovery (2022) · cites this paper as [180]
In the citing paper
“showing that this approach can rapidly identify compounds that target proteins of biological interest.”
From Advances in covalent drug discovery (2022) · cites this paper as [180]
In the citing paper
“The covalent ligands discovered with this approach and their corresponding ligandable sites were used to help elucidate the role of caspase 8 and caspase 10 in extrinsic apoptosis in T cells”
From Advances in covalent drug discovery (2022) · cites this paper as [180]
In the citing paper
“We finally observed limited overlap of enantioprobe targets with proteins that demonstrated ligandability in previous chemical proteomic studies using cysteine-26,27 or lysine-reactive28 electrophilic fragments (Fig. 3b)”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [26]
In the citing paper
“prior to further processing using a well-validated method for covalent ligand target identification—isotopic tandem orthogonal proteolysis ABPP (isoTOP-ABPP) 2,17,26.”
From Manumycin polyketides act as molecular glues between UBR7 and P53 (2020) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 26,294
Self-citationBLAST+: architecture and applications
Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-421 · Cited by 22,074
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M. S., James, C. A. J., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,745
The I-TASSER Suite: protein structure and function prediction
Yang, J., Yan, R., Roy, A., Xu, D., Poisson, J., & Zhang, Y. (2015) · Nature Methods · doi:10.1038/nmeth.3213 · Cited by 5,596
UniProt: a hub for protein information
The UniProt Consortium (2015) · Nucleic Acids Research · doi:10.1093/nar/gku989 · Cited by 5,106
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557
DrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou-Feunang, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,995
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 953
Svenningsen, E. B., Ottosen, R. N., Jørgensen, K. B., Nišavić, M., Larsen, C. K., Hansen, B. K., Wang, Y., Lindorff‐Larsen, K., Tørring, T., Hacker, S. M., et al. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00161f · Cited by 3
Xu, S., Ye, Z., Shang, S., Wang, F., Zhang, H., Chen, L., Lin, H., Chen, C., Hua, F., & Zhang, C. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109034 · Cited by 3
Chemoproteomic Analyses by Activity‐Based Protein Profiling
Killinger, B., Brandvold, K. R., Ramos-Hunter, S. J., & Wright, A. (2019) · Wiley eBooks · doi:10.1002/9781118970195.ch3 · Cited by 3
An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human Immune CellsPreprint
Vinogradova, E. V., Lazar, D. C., Suciu, R. M., Wang, Y., Bianco, G., Yamashita, Y., Crowley, V. M., Remillard, D., Lum, K. M., Simon, G. M., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3476689 · Cited by 3
Self-citationWang, L., Punzalan, C., Bajrami, B., Riel, L. P., Deng, B., Howell, A. R., & Yao, X. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-8w3vf-v2 · Cited by 2
Bonus, M., Greb, J., Majmudar, J. D., Boehm, M., Korczynska, M., Nazemi, A., Mathiowetz, A. M., & Gohlke, H. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5098975 · Cited by 3
Predicting Protein Electrostatics with Protein Language ModelsPreprint
Shen, M., Dayhoff, G. W., Kortzak, D., & Shen, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.17.649309 · Cited by 3
Tsuruno, A., Kamoshita, S., Hosoya, S., & Sakurai, K. (2024) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob01285b · Cited by 2
Phenotypic approaches for CNS drugs
Sharma, R., Oyagawa, C. R. M., Abbasi, H., Dragunow, M., & Conole, D. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.09.003 · Cited by 2
Disruption of Acetyl-CoA Acyltransferase 2 Resulting from Exposure to Diosbulbin B
Jiang, Y., Tan, R., Yang, H. D., Gong, B., Wang, X., Zhang, S., Yang, D., Ye, T., Hu, Z., Peng, Y., et al. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5c00025 · Cited by 2
Designing the Proteome with Chemical Tools: Degrons and Beyond
Seabrook, L. J., Livelo, C. R., & Albrecht, L. V. (2025) · ChemBioChem · doi:10.1002/cbic.202500345 · Cited by 2
Gong, L., Li, S., Sun, J., Liu, K., Wang, S., Ji, M., Hou, P., Li, Y., Yang, D., & Liu, D. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.11.002 · Cited by 2
Identification of EEF1A2 as a potential therapy target of osteosarcoma using novel compound 8e
Xue, J., Li, M., Wang, Y., Sun, D., Hao, S., Liu, Z., Zhang, W., Li, L., Zhu, T., & Liu, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118355 · Cited by 2
Accelerating Covalent Drug Discovery: Recent Advances in Covalent Docking Tools
Li, S. W., Du, H., Zhang, H., Zhang, X., Ye, Y., Shen, C., Hou, T., & Pan, P. (2025) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.70062 · Cited by 2
“Reactive Docking [32] and WIDOCK [33] implement the “reactive docking” concept originally introduced in 2016 [34].”
Activity-based chemoproteomic profiling reveals the active kinome of Leishmania
Porta, E. O. J., Kalesh, K., & Steel, P. G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1687590 · Cited by 2
Neff, J. K., DeMeester, K. E., Solórzano, P. K. P., Suciu, R. M., Dix, M. M., Simon, G. M., Gianakopoulos, M. A., Melillo, B. N., Cravatt, B. F., & Shiloh, M. U. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00984 · Cited by 2
Self-citationSystematic cysteine scanning identifies a druggable pocket in oncogenic KRAS
van Tienen, L. M., Bayoumi, S., Muneeruddin, K., Leymarie, N., Popa, A., Shekhar, M., Mueller, M. A., Li, R., Żak, K. M., Chilukuri, H., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.01.007 · Cited by 2
Jimidar, C. C., Ganskow, C. S. G., Kagho, M. D., Chakrabarti, A., Wiese, L., Zollo, M., Beutling, U., Cesar, L. C., Morud, J., Bugaj, K., et al. (2026) · Chemistry - A European Journal · doi:10.1002/chem.71012 · Cited by 2
Context-dependent synthetic lethality — an emerging precision therapeutic approach
Chang, L., Shaw, K. L., Vázquez, F., & Sellers, W. R. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00929-9 · Cited by 7
de la Lastra, J. M. P., Andrés, C. M. C., Munguira, E. B., Juan, C. A., & Lebeña, E. P. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050529 · Cited by 2
Xiong, Y., Reinhardt, C. J., Nguyen, T., Hoffman, M. A., Simon, G. M., Melillo, B. N., & Cravatt, B. F. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c03985 · Cited by 5
Self-citationPrecision Chemistry for Protein Lysine Modification
Onoda, M., & Kanai, M. (2026) · Chemistry - A European Journal · doi:10.1002/chem.71193 · Cited by 2
The Search for Covalently Ligandable Proteins in Biological Systems
Badshah, S. L., & Mabkhot, Y. N. (2016) · Molecules · doi:10.3390/molecules21091170 · Cited by 2
“These druggable cysteines in the active and inactive states of proteins showed specific structure–activity relationships (SARs) with the available fragment electrophile compounds that can be modified in a more efficient way with less toxicity [11].”
InfluentialProxyBind: A compendium of binding sites for proximity-induced pharmacology
Rovers, E., Liu, L., & Schapira, M. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.010 · Cited by 3
“The method is based on reactivity data for 34 reactive and 184 non-reactive cysteines from isoTOP-ABPP (isotopic tandem orthogonal proteolysis activity-based protein profiling) [19] and a nonredundant set of PDB protein structures (resolution < 2.5 A) with covalently-modified cysteines (272 reactive).”
MethodInfluentialProtein State‐Dependent Chemical Biology
Scott, K. A., Zhang, T. L., Xi, S. Y., Ngo, B., & Vinogradova, E. V. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200101 · Cited by 3
Covalent Modifier Discovery Using Hydrogen/Deuterium Exchange–Mass Spectrometry
Kojima, H., Yanagi, R., Higuchi, E., Yoshizawa, M., Shimodaira, T., Kumagai, M., Kyoya, T., Sekine, M., Egawa, D., Ohashi, N., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01986 · Cited by 2
Ng, W., Xu, T., & Guo, Z. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.04.028 · Cited by 2
Covalency-enabled Drug Discovery is Redefining Druggability
McKenna, J. M., & Proctor, R. S. J. (2023) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2023.537 · Cited by 2
Chemical reagents for the enrichment of modified peptides in MS-based identification
Huangfu, S., Yu, X., Sun, Z., Jiang, B., & Chen, H. (2024) · Chemical Communications · doi:10.1039/d3cc05260e · Cited by 2
Yin, F., Lu, F., Li, Z., Hu, C., Wang, R. Y., An, Y., & Wan, C. (2024) · Synlett · doi:10.1055/s-0042-1751571 · Cited by 2
A Highly Efficient Click Linker for Enrichment of Alkyne‐Tagged Proteins in Living Cells
Qin, G., Duong, S., Fu, Y., & Cai, C. (2024) · Helvetica Chimica Acta · doi:10.1002/hlca.202400031 · Cited by 2
Generating cysteine-trypsin cleavage sites with 2-chloroacetamidine capping
Ofori, S., Desai, H. S., Shikwana, F., Boatner, L. M., Dominguez, E. R., Castellón, J. O., & Backus, K. M. (2024) · Chemical Communications · doi:10.1039/d4cc01583e · Cited by 2
Self-citation12/15-Lipoxygenase-Derived Electrophilic Lipid Modifications in Phagocytic Macrophages
Deng, K., Isobe, Y., Tsumagari, K., Kato, T., Arai, H., Imami, K., & Arita, M. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.4c00624 · Cited by 2
de Oliveira, F. C., Zamoner, L. O. B., Dias‐Baruffi, M., Augusto, B. S., Vaidergorn, M. D. M., Nonato, M. C., Bologna, T. S., da Silva, M. V., & Carvalho, I. (2025) · ACS Omega · doi:10.1021/acsomega.4c11645 · Cited by 2
Synergistic activity of RSL3 and Pyrimethamine to inhibit the proliferation of Plasmodium falciparum
Nikolova, V., Linnemannstöns, K., Zahoruiko, A., Ganter, M., Lüder, C. G. K., & Dobbelstein, M. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00471-25 · Cited by 2
“The chloroacetamide moiety of RSL3 may form covalent bonds with selenohydryl groups, as well as sulfhydryl or imidazole groups (23, 24), suggesting a wide range of potential targets in RBCs or parasites that could interfere with the proliferation of plasmodia. maintained at 37°C in hypoxia…”
[A Review of the Redox Regulation of Tumor Metabolism].
Wang, K., Ming, H., Zuo, J., Tian, H., & Huang, C. (2021) · PubMed Central · doi:10.12182/20210160204 · Cited by 2
Chemical proteomics of reactive molecules
Wang, L., & Yao, X. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821433-6.00008-8 · Cited by 2
Erber, L. N., & Chen, Y. (2021) · ACS in focus · doi:10.1021/acsinfocus.7e5010 · Cited by 2
Xu, J., Peng, L., Guo, C., Xu, F., Lin, D., Tang, Y., & Li, Z. (2022) · ChemBioChem · doi:10.1002/cbic.202200389 · Cited by 2
Jones, L. H. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc256 · Cited by 2
Insights and Future Perspectives of Covalent Protein Degraders
Zhang, X. (2022) · Wiley eBooks · doi:10.1002/9783527836208.ch8 · Cited by 2
White, M. E. H., Gil, J., & Tate, E. W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.12.518491 · Cited by 2
sCIP-ing towards streamlined chemoproteomicsPreprint
Burton, N. R., & Backus, K. M. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-0szhj · Cited by 2
Self-citationCu(II)-Assisted Novel Covalent Warheads for Proteome-wide Cysteine ProfilingPreprint
Fu, S., Yao, Y., Chen, J., Mao, X., Hong, B., & Ni, F. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-nstff · Cited by 1
Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomicsPreprint
Biggs, G. S., Cawood, E. E., Vuorinen, A., McCarthy, W. J., Wilders, H., Riziotis, I. G., van der Zouwen, A. J., Pettinger, J., Nightingale, L., Chen, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.25.605137 · Cited by 2
Rosen, H. T., Li, K., Li, E. L., Currier, B., Brittain, S. M., García, F., Beard, D. C., Haenni‐Holzinger, S., Dovala, D., McKenna, J. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.24.639755 · Cited by 2
Bourne, C. M., Raniszewski, N. R., Kulkarni, M., Exconde, P. M., Liu, S., Yost, W., Wrong, T. J., Patio, R. C., Mahale, A. B., Kardhashi, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.23.639785 · Cited by 2
Jones, H. B. L., Draganov, S. D., Huamán, S. S., Wing, P. A. C., Nguyen, C., Liang, Z., Dörner, J., Lithgow, J., Murphy, E. J., Beard, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.27.656269 · Cited by 2
Covalent Modulators of Immune Regulatory Transcription Factors IRF8 and IRF5Preprint
Cong, T. D., Chan, H., Greene, J., Sabaat, S., Ludwig, C., Abell, N. S., Albert, M. L., Kosuri, S., & Nomura, D. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.03.668300 · Cited by 2
“Subsequent isotopic desthiobiotin-ABPP (isoDTB-ABPP) cysteine chemoproteomic profiling, revealed significant engagement of C223 on IRF8 with 60 other off-targets (Figure 3h; Table S4) 13,14,27 .”
The future of covalent inhibition
Keserű, G. M., & Erlanson, D. A. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.10.003 · Cited by 1
Profiling protein expression in Klebsiella pneumoniae with a carbohydrate-based covalent probe
Métier, C. C., Peng, J., Xu, Y., Wootton, H., Riesi, V., Lynham, S., Zadi, S., Turner, C., Wand, M. E., Sutton, J. M., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115900 · Cited by 1
Thiol modification and signaling by biological electrophiles
Schopfer, F. J., & Vitturi, D. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90219-9.00027-3 · Cited by 1
Ringtail: A Python Tool for Efficient Management and Storage of Virtual Screening Results
Hansel-Harris, A., Santos‐Martins, D., Bruciaferri, N., Tillack, A. F., Holcomb, M., & Forli, S. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00166 · Cited by 1
Self-citationXue, L., van Kalken, D., James, E. M., Giammo, G., Labenski, M., Cantin, S. M., Fahnoe, K. C., Worm, K., Wang, Z., & Corin, A. F. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00326 · Cited by 1
Ouyang, X., Chai, X., Huang, L., Chen, Y., Li, S., Huang, W., Li, Y.-F., Ding, K., Liu, T., Tan, Y., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202504813 · Cited by 1
Gas Phase Separation of Modified Peptides for Activity-Based Protein Profiling
Bellotti, P., Chen, Z., Warren, C. D., & Geri, J. B. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03300 · Cited by 1
Miyachi, H., Koshimizu, M., Ratanasak, M., Shigeta, Y., & Suzuki, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199501 · Cited by 1
“Covalent ligands bearing electrophilic functional groups are particularly effective for targeting “undruggable” proteins, which often exhibit weak or transient interactions with non-covalent ligands [22].”
Zhao, W., Tang, Y., Gao, Y., Ding, Q., Li, Q., Li, W., & Lei, X. (2025) · Angewandte Chemie · doi:10.1002/ange.202515603 · Cited by 1
Ligandability assessment of interferonopathy‐associated proteins using chemoproteomics
Alba, N. M., Jones, C. R., Jones, F. L., & Jones, L. H. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70256 · Cited by 1
Group Competition Strategy for Covalent Ligand Discovery
Guo, Z., Meng, Y., Zhao, B., Xiao, W., & Wang, C. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c18150 · Cited by 1
Leng, J., Huang, Z., Zheng, L., Yang, Y., Huang, H., Gao, Y., Huo, L., Li, Y., Sun, Z., & Zhang, J. Z. H. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp04981d · Cited by 1
Ma, J., Huang, Y., Zheng, T., Wang, H., Li, B., Liu, S., Liu, C., Chen, X., & Min, J. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153815 · Cited by 1
Mapping the SHP2 Allosteric Pocket With Target‐Biased Covalent Fragments
Efrém, N., Csorba, N., Amoussa, M., Ábrányi‐Balogh, P., Guo, Z., Petri, L., Bo, F., di Lorenzo, V., Roske, Y., Szalai, T. V., et al. (2026) · ChemBioChem · doi:10.1002/cbic.70310 · Cited by 1
DMPK Considerations for the Development of Covalent Drugs: Insights from an IQ Assessment
Dopstadt, J., Behnia, K., Cui, X., Colclough, N., Dowty, M. E., Enoru, J. O., Foti, R., Huth, F., Jacobs, F., Jamwal, R., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00214 · Cited by 1
Emerging Role and Potential Therapeutic Application of TRIM Proteins in Cardiovascular Diseases
Cui, Y., Wen, Y., Wang, X., Xu, Y., & Jiang, M. (2026) · Biomolecules · doi:10.3390/biom16050676 · Cited by 1
“Structurally, PROTACs are bifunctional hybrid small molecules composed of a target protein ligand (POI ligand) connected via a chemical linker to an E3 ubiquitin ligase ligand (E3 ligand) [147,148].”
Targeted proteoform degradation for precision drug design, delivery, and therapy
Cui, C., Zhang, H., Wang, X., Li, N., & Zhan, X. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2665871 · Cited by 2
“Existing chemical proteomics techniques can detect cysteine-reactive covalent ligands for undruggable proteins (Backus et al. 2016); additionally, multiple identified covalent E3 ligase ligands can be engineered into PROTACs that degrade target proteins of interest (POI) (Ward et al. 2019; Isobe et…”
Proteolysis‐Assisted Cyclization Facilitates Site‐Centric Target Deconvolution of Isothiocyanates
He, J., Tian, C., Li, Q., Zhang, J., He, J., Zhang, L., Lei, X., & Yang, J. H. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.5512891 · Cited by 1
Al-Karmalawy, A. A., Sippl, W., Al-Dakhil, A., Yousef, T. A., Khatib, A. O. A., & Hawas, S. S. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110065 · Cited by 1
Proteomics‐Driven Strategies for Proximity‐Inducing Drug Discovery
Fan, R., Ni, J., Zhou, T., Jiang, H. Q., Zhao, W., & Tan, M. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.3307512 · Cited by 1
Scaling covalent ligand discovery through dynamic combinatorial library-versus-proteome screening
Huang, Y., Hou, L., He, R., Zhu, L., Xu, C., Duan, S., Hu, J., Yang, X. Y., Tsai, Y., Wang, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74672-y · Cited by 1
“For cysteine targeting, chloroacetamide and acrylamide are well-established 8,64 .”
Covalent Inhibitors in Antimicrobial Drug Development—Beyond β-Lactams
Jafari, G., & Duncan, D. (2026) · Molecules · doi:10.3390/molecules31122186 · Cited by 1
Jiang, J., Chen, Y., Wan, R., Huang, C., Tao, X., Luo, C., Deng, J., Zhang, Z., Liu, T., Tan, Y., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c03429 · Cited by 1
Waters, J. E., Wilders, H., Biggs, G. S., Kintzel, M., Cawood, E. E., Bailey, J., Maslen, S., Yip, Y. M., Wakley, M., Riziotis, I. G., et al. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.8867549 · Cited by 1
“The chloroacetamide handle was selected for its well-characterised reactivity with cysteine residues, synthetic accessibility, balanced electrophilicity, and established utility in covalent fragment-based drug discovery [43–45].”
Pin1 in cancer: Signaling mechanisms, structural basis and advances in inhibitor development
Wu, W., Mo, J., Su, J., Zhu, G., Zhang, Y., Wang, Y., & Zhang, J. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119171 · Cited by 1
An optimized RNF126-targeting covalent handle for molecular glue degraders
Modi, A., Toriki, E. S., Stieger, C. E., Lau, E. A., Song, C., Chew, A. J., Tsao, A. C., Nishikawa, K., McKenna, J. M., & Nomura, D. K. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130743 · Cited by 1
A Perspective on Covalent Hit Identification and Validation in the European Pharmaceutical Industry
Schadt, O., Essig, S., & Testolin, G. (2026) · ChemBioChem · doi:10.1002/cbic.70523 · Cited by 1
“Chemoproteomics and ABPP‐based screening approaches [18] were predominantly employed at low throughput, typically fewer than 100 compounds per project.”
Ecker, A. K., Langen, A., Fields, C. S., Montaño, J. L., Tran, M., Seiple, I. B., & Zaro, B. W. (2026) · ACS Central Science · doi:10.1021/acscentsci.6c00922 · Cited by 1
Tryptoline stereoprobe elaboration identifies inhibitors of the GRPEL1–HSPA9 complex
Hayward, R. E., Berkeley, R. F., Gao, Z., Garhammer, M., Morizono, M. A., Njomen, E., Li, H., DeMeester, K. E., Cociorva, V., Herzik, M. A., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02348-1 · Cited by 5
Self-citationKaneko, R., Kawamura, M., Kishimura, A., Mori, T., & Katayama, Y. (2020) · Analytical Sciences · doi:10.2116/analsci.20scn03 · Cited by 1
Chemoproteomic interrogation of selenocysteine by low-pH isoTOP-ABPP
Bak, D. W., & Weerapana, E. (2022) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2021.10.003 · Cited by 1
Cysteine Reactivity Profiling to Unveil Redox Regulation in Phytopathogens
Morimoto, K., Stegmann, M., Kaschani, F., Mohammed, S., & van der Hoorn, R. A. L. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2079-3_9 · Cited by 1
Benjamin F. Cravatt III – Chemical Proteomics Trailblazer
Hang, H. C. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200066 · Cited by 1
Bak, D. W. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01347-w · Cited by 1
Hayamizu, K., Koike, K., Dodo, K., Asanuma, M., Egami, H., & Sodeoka, M. (2023) · Chemical Science · doi:10.1039/d2sc03112d · Cited by 1
Bishop, A. C., & Serbina, A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3569-8_17 · Cited by 1
Protocol for organelle-specific cysteine capture and quantification of cysteine oxidation state
Julio, A. R., Yan, T., & Backus, K. M. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.102865 · Cited by 1
Self-citationGlobal Profiling Lysine Reactivity and Ligandability with Oxidant‐Triggered Bioconjugation Chemistry
Zhou, M., Li, S., Tan, Y., Huang, W., Li, Y.-F., Yuan, X., & Li, Z. (2024) · Angewandte Chemie · doi:10.1002/ange.202418473 · Cited by 1
Abbas, S. J., Yesmin, S., Vittala, S. K., Sepay, N., Xia, F., Ali, S., Chang, W.-C., Hung, Y., & Ma, W.-L. (2024) · Metabolites · doi:10.3390/metabo14120668 · Cited by 1
“Achieving faster reactivity with higher selectivity requires optimal conditions, such as specific pH and temperature, along with the use of appropriate reagents [32–39].”
Oxygen Starvation Unmasks a Killer
Svec, R. L., & Hergenrother, P. J. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.10.028 · Cited by 1
The Impact of Chemical Biology on Drug Discovery
Plettenburg, O. (2019) · Israel Journal of Chemistry · doi:10.1002/ijch.201900007 · Cited by 1
Rabalski, A. J., Bogdan, A. R., & Baranczak, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/654384 · Cited by 1
Selective inhibitors of JAK1 targeting a subtype-restricted allosteric cysteinePreprint
Kavanagh, M. E., Horning, B. D., Khattri, R., Roy, N., Lu, J. P., Whitby, L. R., Brannon, J. C., Parker, A., Chick, J. M., Eissler, C. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.31.478302 · Cited by 1
Self-citationActivity‐Based Protein Profiling
(2004) · Encyclopedic Dictionary of Genetics, Genomics and Proteomics · doi:10.1002/0471684228.egp00145 · Cited by 1
Wang, L., Punzalan, C., Bajrami, B., Riel, L. P., Deng, B., Howell, A. R., & Yao, X. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-8w3vf · Cited by 1
Chemoproteomics identifies proteoform-selective caspase-2 inhibitorsPreprint
Castellón, J. O., Ofori, S., Armenta, E., Burton, N. R., Boatner, L. M., Takayoshi, E. E., Faragalla, M., Zhou, A., Tran, K., Shek, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.25.563785 · Cited by 1
Self-citationRacioppo, B., Pechalrieu, D., Abegg, D., Dwyer, B. G., Ramseier, N. T., Hu, Y., & Adibekian, A. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-4nm88
Racioppo, B., Pechalrieu, D., Abegg, D., Dwyer, B. G., Ramseier, N. T., Hu, Y., & Adibekian, A. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-4nm88-v2
DNA-encoded Libraries with Covalent Warheads
Liu, S., Jin, R., Duan, Z., & Lu, X. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016032-00119 · Cited by 1
Targeting NEDD9-SH3 with a Covalent Peptide Controls Endothelial PhenotypePreprint
Samokhin, A. O., Seo, H., Leed, A., Hajian, B., Bird, G. H., McKinney, D. C., Saha, P., Daum, J., Moroco, J. A., Yehl, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.10.663547 · Cited by 1
Cobley, J. N. (2025) · Preprints.org · doi:10.20944/preprints202507.2120.v1 · Cited by 5
Metadata
- Authors
- Backus, K. M., Correia, B. E., Lum, K. M., Forli, S., Horning, B. D., González-Páez, G. E., Chatterjee, S., Lanning, B. R., Teijaro, J. R., Olson, A. J., Wolan, D. W., & Cravatt, B. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Backus, Keriann M.
- Cravatt, Benjamin F.
- ORCID
- Venue
- Nature
- Published
- 2016-06-15
- Volume
- 534
- Issue
- 7608
- Pages
- 570-574
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4919207
- OpenAlex
- W2430132928
- Cited by
- 940
- References
- 43
- Citations by year
- 2026: 109 · 2025: 114 · 2024: 114 · 2023: 134 · 2022: 82 · 2021: 94 · 2020: 87 · 2019: 69 · 2018: 61 · 2017: 54 · 2016: 18
- FWCI
- 31.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (CA-087660, R37CA087660, R01CA087660)
- National Institute of General Medical Sciences (GM069832, GM-090294, GM108208, R01GM090294, F32GM108208, R01GM069832)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- covalent ligands, chemical probes, undruggable proteins, transcription factors, caspase-8, caspase-10, extrinsic apoptotic pathway, T cells, protein function
- MeSH terms
- Cells, Cultured, Cysteine, Drug Evaluation, Preclinical, Enzyme Precursors, Humans, Ligands, Peptide Fragments, T-Lymphocytes, Transcription Factors, Apoptosis, Proteome, Caspase 8, Caspase 10, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
